Latest News Archive
Please select Category, Year, and then Month to display items
18 September 2018
Photo Hanno Otto
If Einstein’s string theory had a musical undertone, one would think it is because of the sweet melodies of the Odeion School of Music Cameratas’ (OSMC) violins and cellos. It should therefore come as no surprise that OSMC won the 2018 International Ictus Music Competition, again. The ensemble has been paving the way to numerous successes since its inception in 2012.
This year, however, the OSMC is sharing the first prize with the Oklahoma State University Symphony Orchestra, under the direction of Dr Thomas Dickey. The OSMC’s competition recital for 2018 was conducted by principle conductor, Xavier Cloete. Acclaimed violist Elsabé Raath, joined the OSMC artistic team in 2017 as string clinician.
OSMC the jewel in crown
The OSMC is based at the Odeion School of Music (OSM) at the University of the Free State UFS) and was strategically founded as the OSM’s flagship ensemble with the main objective, creating a catalyst for excellence. “From a pedagogical perspective, it serves as a feasible incubator to nurture fully-rounded musicians who are thoroughly prepared for the demands of their trade as orchestral musicians, soloists and conductors,” said Marius Coetzee founder of the OSMC.
“Ms Raath also made her debut as conductor during the 2018 Ictus Music Competition where she conducted O Sacrum Convivium by Olivier Messiaen,” said Coetzee, founder of the OSMC. Elsabé was also conductor during the 2018 Ictus Music competition.
The OSMC’s concert programme for Ictus 2018 also consisted of works by Jacobus Gallus/Lance Phillip, Béla Bartók, Peteris Vasks/Keith Moss, as well as Johann Sebastian Bach.
Ictus an ideal platform
The Ictus International Music Competition is an online music competition for wind bands, orchestras and solo trumpet. It has been described by David Bilger of the Philadelphia Orchestra as “democratising music competitions”. Ictus was founded to make international music competitions more accessible though eliminating prohibitive travel costs, conference fees and visa issues. This was made possible through having the application and adjudication take place online only.
You can listen to OMSC Ictus submissions here:
Duo Seraphim Jabobus Gallus/Lance Phillip
Romanian Folk Dances/ Román népi táncok Béla Bartók
Kekatu Dziesma (Carnival Song) Peteris Vasks/Keith Moss
DNA sequencer launched at the UFS
2013-11-25
|
Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”